Evidence map›Paper›PMID 35336618›Full record

ArticlePlants (Basel, Switzerland)2022

Growth Optimization and Secondary Metabolites Evaluation of

Dina A Refaay, Mohammed I Abdel-Hamid, Amal A Alyamani, Mamdouh Abdel Mougib, Dalia M Ahmed, Amr Negm, Amr M Mowafy, Amira A Ibrahim, Rania M Mahmoud

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Structural Bioinformatics Applied to Acetylcholinesterase Enzyme Inhibition.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dina A RefaayBotany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
Mohammed I Abdel-HamidBotany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
Amal A AlyamaniDepartment of Biotechnology, Faculty of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0001-6086-5071
Mamdouh Abdel MougibChemistry Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
Dalia M AhmedDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.
Amr NegmChemistry Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0001-9801-3261
Amr M MowafyBotany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
Amira A IbrahimPlant Protection and Biomolecular Diagnosis Department, Arid Lands Cultivation Research Institute, City of Scientific Research and Technological Applications, New Borg El-Arab City 21934, Egypt.ORCID 0000-0002-5904-9736
Rania M MahmoudBotany Department, Faculty of Science, Fayoum University, Fayoum 63514, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacteria comprise a good natural resource of a potential variety of neuro-chemicals, including acetylcholinesterase inhibitors essential for Alzheimer's disease treatment. Accordingly, eight different cyanobacterial species were isolated, identified, and evaluated on their growth on different standard nutrient media. It was found that the modified

Indexed as

4-phenyl-2-(pyridin-3-yl) quinazoline5,7-dihydroxy-2-phenyl-4H-chromen-4-oneacetylcholinesteraseAnabaena variabilisPlackett–Burman

Identifiers

PMID35336618
PMCPMC8948897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.